PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

NCT04301557 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

DMMR Colorectal Cancer
MSI-H Colorectal Cancer
Locally Advanced Colorectal Cancer

Interventions

DRUG: PD-1 Antibody
DRUG: Oxaliplatin
DRUG: Capecitabine
RADIATION: External beam radiotherapy
PROCEDURE: Total mesorectal excision

Sponsor

Sun Yat-sen University